GAMMA Investing LLC Purchases 1,196 Shares of Axcelis Technologies, Inc. $ACLS

GAMMA Investing LLC increased its position in Axcelis Technologies, Inc. (NASDAQ:ACLS) by 75.9% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 2,772 shares of the semiconductor company’s stock after purchasing an additional 1,196 shares during the quarter. GAMMA Investing LLC’s holdings in Axcelis Technologies were worth $193,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. MassMutual Private Wealth & Trust FSB raised its stake in Axcelis Technologies by 50.3% in the second quarter. MassMutual Private Wealth & Trust FSB now owns 481 shares of the semiconductor company’s stock valued at $34,000 after buying an additional 161 shares during the period. Parallel Advisors LLC lifted its holdings in Axcelis Technologies by 129.0% during the 2nd quarter. Parallel Advisors LLC now owns 545 shares of the semiconductor company’s stock valued at $38,000 after purchasing an additional 307 shares during the last quarter. Fifth Third Bancorp boosted its holdings in shares of Axcelis Technologies by 160.5% during the 1st quarter. Fifth Third Bancorp now owns 581 shares of the semiconductor company’s stock worth $29,000 after buying an additional 358 shares during the period. Versant Capital Management Inc grew its stake in Axcelis Technologies by 118.7% in the 1st quarter. Versant Capital Management Inc now owns 584 shares of the semiconductor company’s stock valued at $29,000 after buying an additional 317 shares during the last quarter. Finally, Bayforest Capital Ltd acquired a new position in Axcelis Technologies in the 1st quarter valued at about $38,000. 89.98% of the stock is currently owned by institutional investors and hedge funds.

Axcelis Technologies Stock Performance

Shares of NASDAQ:ACLS opened at $97.48 on Monday. Axcelis Technologies, Inc. has a 12-month low of $40.40 and a 12-month high of $109.47. The company’s 50 day moving average price is $81.90 and its two-hundred day moving average price is $66.97. The firm has a market cap of $3.06 billion, a PE ratio of 19.93 and a beta of 1.73. The company has a quick ratio of 4.26, a current ratio of 6.01 and a debt-to-equity ratio of 0.04.

Axcelis Technologies (NASDAQ:ACLS) last released its quarterly earnings results on Tuesday, August 5th. The semiconductor company reported $1.13 earnings per share for the quarter, beating analysts’ consensus estimates of $0.73 by $0.40. The company had revenue of $194.54 million during the quarter, compared to the consensus estimate of $185.15 million. Axcelis Technologies had a net margin of 17.69% and a return on equity of 16.26%. The firm’s quarterly revenue was down 24.2% on a year-over-year basis. During the same period in the previous year, the business earned $1.55 earnings per share. Axcelis Technologies has set its Q3 2025 guidance at 1.000-1.000 EPS. Equities research analysts predict that Axcelis Technologies, Inc. will post 2.55 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on ACLS. B. Riley boosted their price objective on Axcelis Technologies from $58.00 to $75.00 and gave the stock a “neutral” rating in a report on Wednesday, June 18th. DA Davidson lifted their price target on Axcelis Technologies from $75.00 to $90.00 and gave the stock a “buy” rating in a report on Wednesday, August 6th. Two analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, Axcelis Technologies has an average rating of “Hold” and a consensus target price of $90.00.

About Axcelis Technologies

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.